Spain Brazil Russia France Germany China Korea Japan

Artificial Intelligence driven Marketing Communications

Jun 18, 2019 6:49 AM ET

Branded Generics Market Analysis 2018-2027: Mylan, Teva Pharmaceutical Industries, GlaxoSmithKline, Bausch Health, Sandoz International, Zydus Cadila, Par Pharmaceutical, Lupin Pharmaceuticals, Sanofi, AstraZeneca, and Dr. Reddy's Laboratories

iCrowd Newswire - Jun 18, 2019

Branded Generics are a patented drug, a novel dosage form of a generic drug with a definite trade name. The manufactures opt for this to gain profit from their customers who realize their medication has come off patent and that there are cheaper generics available.


The Branded Generics market is anticipated to grow in the forecast, owing to the factors such as increasing off patent pharmaceutical companies, entry of new market players, changing medicine practices and rising awareness of the patients. 


Get PDF sample copy: https://www.theinsightpartners.com/sample/TIPRE00005554/


The global Branded Generics market is segmented on the basis of therapeutic application, distribution channel, drug class and formulation type. Based on therapeutic application the market is segmented into oncology, cardiovascular diseases, diabetes, neurology, gastrointestinal diseases, dermatology diseases, analgesics and anti-inflammatory. Based on distribution channel the market is segmented into Hospitals pharmacies, Retail pharmacies. Online pharmacies, Drug stores. Based on drug class the market is segmented into Alkylating Agents, Antimetabolites, Hormones, Anti-Hypertensive, Lipid Lowering Drugs, Anti-Depressants, Anti-Psychotics, Anti-Epileptic, Others. Based on Formulation type the market is segmented into Oral, Parental, Topical, Others. 


The List of Companies

– Mylan N.V
– Teva Pharmaceutical Industries Ltd
– GlaxoSmithKline plc
– Bausch Health (Valeant Pharmaceuticals)
– Sandoz International GmbH
– Zydus Cadila
– Par Pharmaceutical
– Lupin Pharmaceuticals, Inc
– Sanofi
– AstraZeneca
– Dr. Reddy’s Laboratories Ltd

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Branded Generics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Branded Generics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Branded Generics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Branded Generics market in these regions.

Contact Information:

Contact Us:
Call: +1-646-491-9876
Email: [email protected]
Web: https://www.theinsightpartners.com/

Tags:    Research Newswire, English